AstraZeneca PLC Profile Avatar - Palmy Investing

AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza…
Drug Manufacturers - General
GB, Cambridge [HQ]

News

Theses · Events · Sentiments
Sentiments
24-11-21 46.40%

3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now

24-11-19 36.60%

In its latest outlook for 2025, Goldman Sachs is urging investors to “buy British” as undervalued UK stocks offer an …

24-11-08 1.20%

AstraZeneca PLC (LSE:AZN) and Amgen Inc (NASDAQ:AMGN, ETR:AMG) have unviled positive results from their phase III WAYPOINT study, which tested …

24-11-06 -35.00%

AstraZeneca PLC (LSE:AZN) has committed to working with Chinese authorities after reports several executives were implicated in a fraud case …